2024-12-20
IK Partners to sell Mecenat to Inflexion
Read More
2022-06-23
Safic-Alcan, together with six private equity funds, announces the start of a new entrepreneurial project
The executive team of Safic-Alcan, together with their existing private equity funds partners, namely EMZ partners, Sagard and Société Générale Capital Partenaires are pleased to announce the start of their next project.
All three historical partners will continue to invest alongside the management and will be reinforced by three new private equity funds, namely Equistone, IK Partners and GENEO Capital Entrepreneur.
This transaction constitutes a new phase in the development of Safic-Alcan, that attained a new milestone at the end of 2021, by reaching a turnover of €725 million. Safic-Alcan will continue to be majority-owned by its management and employees.
Yann Lissillour, CEO of Safic-Alcan since April 2022, declared: “We are delighted to continue our entrepreneurial project with our long-term partners EMZ, Sagard and SGCP and to welcome our new additional partners Equistone, IK and GENEO Capital Entrepreneur. We believe we have an extremely solid line up, that will provide the backbone of our ongoing future growth and the independence of our Group is further assured.”
Antoine Ernoult-Dairaine (Sagard) and Thierry Raiff (EMZ) added: “We are very happy to renew our long-term involvement alongside Safic-Alcan for a new chapter of its successful development worldwide. We would like to deeply thank Martial Lecat for his exceptional contribution over the past years we spent together and are very confident that Yann Lissillour and his team will reaffirm the leadership of Safic-Alcan on its various lines of business”.
Guillaume Jacqueau (Equistone) and Thomas Grob (IK Partners) added: “We have been following Safic Alcan’s impressive journey for a long time and are extremely excited to work alongside its management team over the next few years. We look forward to assisting them with the Company’s continued development and supporting their ambitious growth strategy”.
Marc Diamant (SGCP) et François Rivolier (GENEO Capital Entrepreneur) added: “We have built a strong relationship with Safic Alcan’s management team over time and we are very honored to be part of this new growth cycle together with solid and performing managers and financial partners”.
About Safic-Alcan
About Safic-Alcan is a French independent distributor of specialty chemicals headquartered in Paris La Défense (France). The Company develops and provides wide ranges of polymers, materials and additives for the rubber, coatings, adhesives, thermoplastics, polyurethane, lubricants, detergency, cosmetics, pharmaceuticals, and nutraceuticals industries. With a network of 32 offices strategically located in Europe, Turkey, Middle East, North America, Mexico China and South Africa, the company represents state-of-the art manufacturers around the world. Its highly specialized sales engineers allow Safic-Alcan to provide dedicated technical expertise and high-performance solutions thus creating long term partnership with most of its principals and customers. Safic-Alcan employs 697 people worldwide and generated a turnover of 725 M€ in 2021. For more information, visit www.safic-alcan.com
If you have any questions regarding this announcement, please reach out to one of the key contacts on the PDF of this release.
About EMZ
EMZ is an independant specialist fund investing alongside leading company managers willing to acquire or consolidate the control of their capital. With 15 investment professionals based in Paris and Münich, EMZ has invested in more than 150 transactions since 1999. First investment in Safic-Alcan was done in 2007. Team members in charge of the deal: Thierry Raiff, Ajit Jayaratnam, Ludovic Bart, Mathieu Barlet. For more information, visit www.emzpartners.com
About Sagard
Sagard is a French investment fund that provides equity capital to support the development of mid-sized companies led by ambitious management teams. Founded in 2003 with the support of the Desmarais family, Sagard’s investor base comprises leading industrial families as well as blue chip institutional investors. Since its inception, Sagard and its Paris-based team of 12 professionals have invested in 40 industrial and service companies in France. The Sagard team comprises Antoine Ernoult-Dairaine, Maxime Baudry, Charlotte Kitabgi and Nasser Bounjou. For more information, visit www.equity-partners.sagard.eu
About Société Générale Capital Partenaires (SGCP)
For more than 30 years, Société Générale Capital Partenaires (SGCP) has supported founders and managers of SMEs through a proactive and close relationship. SGCP takes minority stakes in the capital of companies, for amounts between € 1mln and €35mln in various contexts: new phase of development, shareholder restructuring, optimization of the financial structure, transmission. Every year, the SGCP teams, based in Paris, Lille, Strasbourg, Lyon, Marseille, Bordeaux and Rennes, invest more than a hundred million euros in some fifteen operations, confirming their long-term commitment to financing companies and the economy. For more information, visit www.capitalpartenaires.societegenerale.com
About Equistone Partners Europe Limited
Equistone is an independent investment firm wholly-owned and managed by its executives.
The company is one of Europe’s leading investors in mid-market buyouts with a strong, consistent track record spanning over 40 years, with more than 400 transactions completed in this period. Equistone has a strong focus on change of ownership deals and aims to invest between €25m and €200m+ of equity in businesses with enterprise values of between €50m and €500m. The company has a team of over 40 investment professionals operating across France, Germany, Switzerland and the UK, investing as a strategic partner alongside management teams. Equistone is currently investing its sixth buyout fund, which held a final closing at its €2.8bn hard cap in March 2018, and has recently launched the Equistone Reinvestment Fund, with a mandate to make minority re-investments alongside new sponsors following a portfolio company exit from one of its main buyout funds.
Equistone is authorised and regulated by the Financial Conduct Authority. For more information, visit www.equistonepe.com
About GENEO Capital Entrepreneur
The purpose of GENEO Capital Entrepreneur is to provide small and mid-caps with positive finance and reveal their full potential of value creation and impact.
With 600meuros under management, including through an evergreen equity investment company, GENEO is a business partner able to provide tailored equity solutions and pursue ambitious strategies over time. Our team is structured to provide operational support and expertise, with dedicated human resources for M&A, digitalization, innovation, CSR and impact, and a pool of more than 70 specialists. Our investors, including financial institutions and more than 200 entrepreneurs and families, form a real “GENEO Community” willing to share experience and business networks. When we invest, we commit! For more information, visit www.geneocapitalentrepreneur.com
About IK Partners
IK Partners (“IK”) is a European private equity firm focused on investments in the Benelux, DACH, France, Nordics and the UK. Since 1989, IK has raised more than € 14 billion of capital and invested in over 160 European companies. IK supports companies with strong underlying potential, partnering with management teams and investors to create robust, well-positioned businesses with excellent long-term prospects. For more information, visit www.ikpartners.com
Recent News
2024-12-19
Eurobio Scientific: EB Development obtains a significant majority of the capital with 88.9% held at the end of the Reopened Offer to continue its development with NextStage AM and IK Partners
Read More
2024-12-16
IK Partners to acquire majority stake in Dains alongside management
Read More
2024-12-12
Rivean Capital has acquired a majority stake in Acture Group from IK Partners
Read More
